over 24 years of clinical trial experience
since the first HUMIRA trial in 1997.
More than 1.4 million patients worldwide
have been prescribed HUMIRA for an FDA-approved condition.*
*As of July 2020.
Get the facts
What is HUMIRA Citrate-free?
HUMIRA Citrate-free
works the same as original HUMIRA, but with less pain immediately following injection.*
Ask your doctor if HUMIRA Citrate-free may be right for you.
*Compared to HUMIRA 40 mg/0.8 mL.
The resources you need, when you need them.
HUMIRA Complete is more than just a support program. It’s our promise to be there for you with the information and resources you need to start and stay on track with HUMIRA.
Our dedicated Ambassadors* are the heart of HUMIRA Complete.
Your Ambassador is there to get to know you and your treatment needs to provide you with personalized, 1-to-1 help every step of the way.
Prefer to meet virtually? Ask your Ambassador if virtual visits are available.
You can also ask your Ambassador for help connecting you with resources, such as:
Your Ambassador is always here to help you.
If you have questions or need help accessing the resources above, reach out to your Ambassador or call 1.800.4HUMIRA (1.800.448.6472).
Get the facts
How much experience do Nurse Ambassadors* have?
19 years
Nurse Ambassadors* have an average of 19 years of nursing experience.
*Nurse Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.
Eligibility: Available to patients with commercial insurance coverage for HUMIRA® (adalimumab) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit HUMIRASavingsCard.com or call 1.800.4HUMIRA for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy
Understanding a complex condition.
The more you know about non-infectious uveitis* and what to expect, the easier it may be to understand your condition. This can also help you explain your experience to others.
*Intermediate, posterior, and panuveitis in adults and children 2 years of age and older.
A chronic inflammatory condition that affects your eyes
Uveitis is inflammation of the middle layer of the eye, called the uvea. This layer has many blood vessels that nourish the eye.
Non-infectious uveitis can be acute, lasting for a short period of time, or chronic, lasting for a long period of time.
Where it strikes
Uveitis can affect different parts of the eye, including:
- The middle of the eye (“intermediate uveitis”)
- Toward the back of the eye (“posterior uveitis”)
- All parts of the eye (“panuveitis”)
WHAT CAUSES UVEITIS?
The exact cause of uveitis is unknown. It may be triggered by a bacterial or viral infection, your genes, trauma, or your immune system.
Infectious or non-infectious
While the exact cause of uveitis is unknown, it may be triggered by your immune system, genetics, trauma, or by bacterial or viral infection. When it is caused by bacteria or a virus, it is called "infectious uveitis." When it's not caused by an infection, it's called "non-infectious uveitis."
Get the facts
What specialists may play a role in your treatment plan?
An ophthalmologist, a retinal specialist, a uveitis specialist, and a rheumatologist may all play a role in your uveitis treatment plan.
A combination of factors.
Anyone can get non-infectious uveitis,* but there are risk factors that may increase your chances. Talk to your doctor to learn more about possible risk factors.
*Intermediate, posterior, and panuveitis in adults and children 2 years of age and older.
Age
Uveitis primarily affects people between the ages of 20 and 60 years old.
Smoking
A study has found a link between uveitis and cigarette smoking.
Ethnicity
Caucasians have a higher share of uveitis cases than the general population.
Family History
A family history of autoimmune diseases can increase your risk of developing non-infectious uveitis.
The immune system/inflammation connection.
Normally, the immune system protects your body by attacking disease-causing germs, including bacteria and viruses. But with non-infectious uveitis,* the immune system becomes overactive.
*Intermediate, posterior, and panuveitis in adults and children 2 years of age and older.
Immune System Overreacts
The immune system mistakenly sends white blood cells rushing to your eye.
A chain reaction
This sets off a cascade of reactions causing activation of other cells and proteins involved in inflammatory response, such as tumor necrosis factor-alpha (TNF-alpha).
Inflammation
The result is chronic inflammation that can cause eye pain, eye redness, blurred vision, and other uveitis symptoms.
More than just eye pain and redness.
The most common uveitis* signs and symptoms may include:
Eye pain
Eye redness
Blurred or cloudy vision
Sensitivity to light
Floaters
small shapes that move slowly across your vision
Loss of peripheral vision
loss of the ability to see objects at the far edges of your vision
These symptoms can affect just one eye or both. They may develop suddenly or gradually over a few days.
*Intermediate, posterior, and panuveitis in adults and children 2 years of age and older.
How HUMIRA works in your body.
No one knows exactly what causes non-infectious uveitis,* but we do know that several proteins produced in your body are involved. One of these proteins your body naturally produces is called tumor necrosis factor-alpha (TNF-alpha). With uveitis, your body may produce too much TNF-alpha.
HUMIRA works by targeting excess TNF-alpha and blocking it in order to help reduce inflammation that may contribute to uveitis symptoms like changes in vision, blurred or cloudy vision, and sensitivity to light.
*Intermediate, posterior, and panuveitis in adults and children 2 years of age and older.
HUMIRA can help control non-infectious uveitis.*
In a clinical study of adult patients with active disease, HUMIRA was shown to increase the time that non-infectious uveitis was controlled.
50%
50% decrease in risk.
Patients who took HUMIRA saw a 50% decrease in 4 combined measurements—the first 3 contribute to what’s commonly known as a “flare”:
- Vitreous haze (cloudiness in the middle of the eye)
- Inflammatory cells in the front of the eye
- New lesions of the back of the eye
- Inability to maintain visual clarity (reading an eye chart at a distance)
Results as early as 6 weeks.†
Differences in disease control were seen as early as Week 6 for patients taking HUMIRA.
*Intermediate, posterior, and panuveitis in adults and children 2 years of age and older.
†Individual results may vary.
Before making a decision, get the facts.
Discuss Important Safety Information for HUMIRA with your doctor.
Before you and your doctor make a decision about treatment, you should discuss the Important Safety Information for HUMIRA. Talk about any concerns you may have. Working together, you and your doctor can find a treatment that is right for you.
What is the most important information I should know about HUMIRA?
You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a tumor necrosis factor (TNF) blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.
- Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
- Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.
Learn about the most common side effects of HUMIRA.
Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.
It is possible to experience adverse events or side effects from HUMIRA. If you do experience any side effects, call your doctor right away. These are not all of the possible side effects associated with HUMIRA. Click here to see additional Important Safety Information.